Isolated Compounds from Buddleja Coriacea with Antibacterial and Anti-Inflammatory Activities in the Urinary Tract
Planta Medica International Open · 01.06.2022 · 9 (01) · e12-e22
DOI: 10.1055/a-1696-6851 ↗Kurz gefasst
Fachartikel in der Zeitschrift Planta Medica International Open, erschienen am 01.06.2022. Verfasst von Luis Apaza Ticona und 4 weiteren Autor:innen. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Buddleja coriacea Remy is one of the plant species used by the Bolivian population for the treatment of urinary infections. This study aimed to identify the extract, fractions, and compounds responsible for the antibacterial and anti-inflammatory activities of B. coriacea leaves. Bioguided isolation of compounds with antibacterial and anti-inflammatory activities was carried out by measuring the antibacterial effect against specific pathogenic microbial strains, Klebsiella pneumoniae, Proteus mirabilis, Pseudomonas aeruginosa, and Serratia marcescens, and the inhibition of NF-κB in RM-2 and MM.14Ov cells. Bioassay-guided isolation led to the isolation and characterisation of (4aR,4bS,5 S,6aS,6bS,9aR,10aS,10bS)-6b-glycoloyl-5-hydroxy-4a,6a-dimethyl-8-propyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho [2',1':4,5] indeno [1,2-d][1,3] dioxol-2-one (1), 3-[3-(2-dimethylaminoethyl)-1H-indol-5-yl]-N-(4-methoxybenzyl) acrylamide (2), and (1β,11β,12α)-1,11,12-trihydroxy-11,20-epoxypicrasa-3,13(21)-diene-2,16-dione (3) by nuclear magnetic resonance and mass spectroscopy. All compounds showed antibacterial activity with minimum inhibitory concentration values of 11.64–11.81, 0.17–0.19, and 0.34–0.36 µM, respectively, on the tested strains, while the positive control, ofloxacin, had a minimum inhibitory concentration of 27.66 µM. Finally, all the compounds showed NF-κB inhibitory activity with IC50 values of 11.25–11.34, 0.15–0.16, and 0.33–0.36 µM, respectively, in all cell lines, while the positive control, celastrol, had an IC50 of 7.96 µM. Thus, this study managed to isolate and evaluate for the first time the pharmacological potential of three compounds present in the leaves of B. coriacea with antibacterial and anti-inflammatory activities.
Zitieren
APA
Ticona, L. A., Rico, F. A., Sánchez-Corral, J. S., Domenech, M. O., & Sánchez, Á. R. (2022). Isolated Compounds from Buddleja Coriacea with Antibacterial and Anti-Inflammatory Activities in the Urinary Tract. Planta Medica International Open, 9(01), e12-e22. https://doi.org/10.1055/a-1696-6851
Vancouver
Ticona LA, Rico FA, Sánchez-Corral JS, Domenech MO, Sánchez ÁR. Isolated Compounds from Buddleja Coriacea with Antibacterial and Anti-Inflammatory Activities in the Urinary Tract. Planta Medica International Open. 2022;9(01):e12-e22. doi:10.1055/a-1696-6851
BibTeX
@article{Ticona2022,
author = {Ticona, Luis Apaza and Rico, Francisco Aguilar and Sánchez-Corral, Javier Sánchez and Domenech, Montserrat Ortega and Sánchez, Ángel Rumbero},
title = {Isolated Compounds from Buddleja Coriacea with Antibacterial and Anti-Inflammatory Activities in the Urinary Tract},
journal = {Planta Medica International Open},
year = {2022},
volume = {9},
number = {01},
pages = {e12--e22},
doi = {10.1055/a-1696-6851}
}
EUVIMED